Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
Claudia Ricci, Carlotta Marzocchi, Stefania Battistini
Cells (2018) Vol. 7, Iss. 11, pp. 219-219
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Julia Konovalova, Dmytro Gerasymchuk, Ilmari Parkkinen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6055-6055
Open Access | Times Cited: 175
miRNA-214 to predict progression and survival in ALS
Min‐Young Noh, Min‐Soo Kwon, Ki‐Wook Oh, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335177
Closed Access | Times Cited: 2
Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease
Callum N. Watson, Antonio Belli, Valentina Di Pietro
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 129
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
Hirosha Geekiyanage, Shima Rayatpisheh, James A. Wohlschlegel, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 39, pp. 24213-24223
Open Access | Times Cited: 111
Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders
Sujay Paul, Luis Alberto Bravo-Vázquez, Samantha Pérez Uribe, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1698-1698
Open Access | Times Cited: 98
MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
Mariano Catanesi, Michele d’Angelo, Maria Grazia Tupone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5986-5986
Open Access | Times Cited: 87
Cerebrospinal Fluid (CSF) Analysis and Interpretation in Neurocritical Care for Acute Neurological Conditions
Ajay Prasad Hrishi, Manikandan Sethuraman
Indian Journal of Critical Care Medicine (2019) Vol. 23, Iss. S2, pp. 115-119
Open Access | Times Cited: 84
Ropinirole, a New ALS Drug Candidate Developed Using iPSCs
Hideyuki Okano, Daisuke Yasuda, Koki Fujimori, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 2, pp. 99-109
Open Access | Times Cited: 81
Seminal exosomes – An important biological marker for various disorders and syndrome in human reproduction
A. S. Vickram, P. S. Srikumar, S. Srinivasan, et al.
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 6, pp. 3607-3615
Open Access | Times Cited: 58
The role of microRNAs in neurobiology and pathophysiology of the hippocampus
Seyed Khalil Rashidi, Ata Kalirad, Shahram Rafie, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 24
Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review
Shahram Darabi, Armin Ariaei, Auob Rustamzadeh, et al.
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10
A New Discovery of MicroRNA-455-3p in Alzheimer’s Disease
Subodh Kumar, P. Hemachandra Reddy
Journal of Alzheimer s Disease (2019) Vol. 72, Iss. s1, pp. S117-S130
Closed Access | Times Cited: 59
A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients
Gabriella Dobrowolny, Julie Martone, Elisa Lepore, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 55
Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
Xiaoming Yang, Yanan Ji, Wei Wang, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1012-1012
Open Access | Times Cited: 54
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Silvia Bono, Marco Feligioni, Massimo Corbo
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 48
Small RNA sequencing of circulating small extracellular vesicles microRNAs in patients with amyotrophic lateral sclerosis
Jinah Kim, Canaria Park, Jung‐Joon Sung, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review
Hafiz Muhammad Husnain Azam, Rosa Rößling, Christiane Geithe, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 7
A microRNA diagnostic biomarker for amyotrophic lateral sclerosis
Sandra Anne Banack, Rachael A. Dunlop, Paul Mehta, et al.
Brain Communications (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 7
From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis
Giovanna Morello, Salvatore Salomone, Velia D’Agata, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 44
Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons
Marta Barbosa, Cátia Gomes, Catarina Sequeira, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 37
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
Mafalda Rizzuti, Valentina Melzi, Delia Gagliardi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 25
Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation
Narges Daneshafrooz, Mohammad Taghi Joghataei, Mehdi Mehdizadeh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases
Takashi Hosaka, Takenari Yamashita, Akira Tamaoka, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3148-3148
Open Access | Times Cited: 41
Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
Laura Moreno‐Martínez, Ana Cristina Calvo, Marı́a Jesús Muñoz, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2759-2759
Open Access | Times Cited: 40
MicroRNA‑21‑5p targeting PDCD4 suppresses apoptosis via regulating the PI3K/AKT/FOXO1 signaling pathway in tongue squamous cell carcinoma
Changfu Liu, Tong Zhou, Tan Jingyu, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top